↓ Skip to main content

Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms

Overview of attention for article published in Journal of Hematology & Oncology, April 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
70 Dimensions

Readers on

mendeley
162 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms
Published in
Journal of Hematology & Oncology, April 2019
DOI 10.1186/s13045-019-0725-6
Pubmed ID
Authors

Zeinab Safarpour Lima, Mostafa Ghadamzadeh, Farzad Tahmasebi Arashloo, Ghazaleh Amjad, Mohammad Reza Ebadi, Ladan Younesi

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 162 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 162 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 14%
Student > Bachelor 21 13%
Researcher 16 10%
Other 12 7%
Student > Doctoral Student 8 5%
Other 25 15%
Unknown 58 36%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 33 20%
Medicine and Dentistry 21 13%
Agricultural and Biological Sciences 11 7%
Pharmacology, Toxicology and Pharmaceutical Science 9 6%
Immunology and Microbiology 6 4%
Other 17 10%
Unknown 65 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 May 2023.
All research outputs
#3,085,665
of 23,659,844 outputs
Outputs from Journal of Hematology & Oncology
#239
of 1,222 outputs
Outputs of similar age
#68,451
of 354,660 outputs
Outputs of similar age from Journal of Hematology & Oncology
#12
of 25 outputs
Altmetric has tracked 23,659,844 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,222 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.9. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,660 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.